Cpep Gp, LLC insider trades: Medline (MDLN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Cpep Gp, LLC reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | MDLN | ↓ Sell | 26,105,840 | $41.00 | $1.07B | Indirect | Mar 12, 2026 (2d) |
| Dec 18, 2025 | MDLN | ↓ Sell | 19,136,333 | $29.00 | $555.0M | Indirect | Dec 22, 2025 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MDLN insiders
Open-market trades in the last 12 months
About Cpep Gp, LLC's insider trades
Cpep Gp, LLC is a 10% owner of Medline (MDLN). Since Dec 18, 2025, it has reported no open-market purchases and 2 sales worth $1.63B on SEC Form 4. In the last 12 months: 2 sales ($1.63B).
Its filings also include other transactions (3 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDLN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.